FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064852078> ?p ?o ?g. }

• W2064852078 endingPage "915" @default.
• W2064852078 startingPage "905" @default.
• W2064852078 abstract "Mu-opioid and CB1-cannabinoid agonists produce analgesia; however, adverse effects limit use of drugs in both classes. Additive or synergistic effects resulting from concurrent administration of low doses of mu- and CB1-agonists may produce analgesia with fewer side effects. Synergism potentially results from interaction between mu-opioid receptors (MORs) and CB1 receptors (CB1Rs). AM-251 and rimonabant are CB1R antagonist/inverse agonists employed to validate opioid–cannabinoid interactions, presumed to act selectively at CB1Rs. Therefore, the potential for direct action of these antagonists at MORs is rarely considered. This study determined if AM-251 and/or rimonabant directly bind and modulate the function of MORs. Surprisingly, AM-251 and rimonabant, but not a third CB1R inverse agonist AM-281, bind with mid-nanomolar affinity to human MORs with a rank order of affinity (Ki) of AM-251 (251 nM) > rimonabant (652 nM) > AM281 (2135 nM). AM-251 and rimonabant, but not AM-281, also competitively antagonize morphine induced G-protein activation in CHO-hMOR cell homogenates (Kb = 719 or 1310 nM, respectively). AM-251 and rimonabant block morphine inhibition of cAMP production, while only AM-251 elicits cAMP rebound in CHO-hMOR cells chronically exposed to morphine. AM-251 and rimonabant (10 mg/kg) attenuate morphine analgesia, whereas the same dose of AM-281 produces little effect. Therefore, in addition to high CB1R affinity, AM-251 and rimonabant bind to MORs with mid-nanomolar affinity and at higher doses may affect morphine analgesia via direct antagonism at MORs. Such CB1-independent actions of these antagonists may contribute to reported inconsistencies when CB1/MOR interactions are examined via pharmacological methods in CB1-knockout versus wild-type mice." @default.
• W2064852078 created "2016-06-24" @default.
• W2064852078 creator A5005737115 @default.
• W2064852078 creator A5045811374 @default.
• W2064852078 creator A5049198562 @default.
• W2064852078 creator A5072010643 @default.
• W2064852078 creator A5079385875 @default.
• W2064852078 creator A5082880502 @default.
• W2064852078 creator A5083314761 @default.
• W2064852078 date "2012-10-01" @default.
• W2064852078 modified "2023-10-13" @default.
• W2064852078 title "AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies" @default.
• W2064852078 cites W1487872499 @default.
• W2064852078 cites W1599311640 @default.
• W2064852078 cites W1607901775 @default.
• W2064852078 cites W1699530412 @default.
• W2064852078 cites W1812356957 @default.
• W2064852078 cites W1866046632 @default.
• W2064852078 cites W1945938111 @default.
• W2064852078 cites W1966476393 @default.
• W2064852078 cites W1974089422 @default.
• W2064852078 cites W1974564599 @default.
• W2064852078 cites W1975748753 @default.
• W2064852078 cites W1987007555 @default.
• W2064852078 cites W1988345024 @default.
• W2064852078 cites W1988365630 @default.
• W2064852078 cites W1991132716 @default.
• W2064852078 cites W1995338592 @default.
• W2064852078 cites W1995552285 @default.
• W2064852078 cites W1995857480 @default.
• W2064852078 cites W2000895369 @default.
• W2064852078 cites W2002935274 @default.
• W2064852078 cites W2011204298 @default.
• W2064852078 cites W2018769395 @default.
• W2064852078 cites W2018953051 @default.
• W2064852078 cites W2029908981 @default.
• W2064852078 cites W2036908810 @default.
• W2064852078 cites W2038784126 @default.
• W2064852078 cites W2040320300 @default.
• W2064852078 cites W2041956252 @default.
• W2064852078 cites W2044429277 @default.
• W2064852078 cites W2046216423 @default.
• W2064852078 cites W2048001574 @default.
• W2064852078 cites W2054203254 @default.
• W2064852078 cites W2055615777 @default.
• W2064852078 cites W2058051322 @default.
• W2064852078 cites W2059977407 @default.
• W2064852078 cites W2061601726 @default.
• W2064852078 cites W2074631079 @default.
• W2064852078 cites W2079730161 @default.
• W2064852078 cites W2085008837 @default.
• W2064852078 cites W2091435411 @default.
• W2064852078 cites W2108443815 @default.
• W2064852078 cites W2110133277 @default.
• W2064852078 cites W2119867825 @default.
• W2064852078 cites W2130010679 @default.
• W2064852078 cites W2134141692 @default.
• W2064852078 cites W2135962544 @default.
• W2064852078 cites W2136490245 @default.
• W2064852078 cites W2153424052 @default.
• W2064852078 cites W2163364932 @default.
• W2064852078 cites W2165518874 @default.
• W2064852078 cites W2166097649 @default.
• W2064852078 cites W2166781208 @default.
• W2064852078 cites W2171584675 @default.
• W2064852078 cites W2185149735 @default.
• W2064852078 cites W3189565531 @default.
• W2064852078 cites W4230381786 @default.
• W2064852078 cites W4238102997 @default.
• W2064852078 doi "https://doi.org/10.1016/j.neuropharm.2012.06.046" @default.
• W2064852078 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3408547" @default.
• W2064852078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22771770" @default.
• W2064852078 hasPublicationYear "2012" @default.
• W2064852078 type Work @default.
• W2064852078 sameAs 2064852078 @default.
• W2064852078 citedByCount "80" @default.
• W2064852078 countsByYear W20648520782012 @default.
• W2064852078 countsByYear W20648520782013 @default.
• W2064852078 countsByYear W20648520782014 @default.
• W2064852078 countsByYear W20648520782015 @default.
• W2064852078 countsByYear W20648520782016 @default.
• W2064852078 countsByYear W20648520782017 @default.
• W2064852078 countsByYear W20648520782018 @default.
• W2064852078 countsByYear W20648520782019 @default.
• W2064852078 countsByYear W20648520782020 @default.
• W2064852078 countsByYear W20648520782021 @default.
• W2064852078 countsByYear W20648520782022 @default.
• W2064852078 countsByYear W20648520782023 @default.
• W2064852078 crossrefType "journal-article" @default.
• W2064852078 hasAuthorship W2064852078A5005737115 @default.
• W2064852078 hasAuthorship W2064852078A5045811374 @default.
• W2064852078 hasAuthorship W2064852078A5049198562 @default.
• W2064852078 hasAuthorship W2064852078A5072010643 @default.
• W2064852078 hasAuthorship W2064852078A5079385875 @default.
• W2064852078 hasAuthorship W2064852078A5082880502 @default.
• W2064852078 hasAuthorship W2064852078A5083314761 @default.
• W2064852078 hasBestOaLocation W20648520782 @default.
• W2064852078 hasConcept C14397066 @default.

• next